The Lymphoma Research Foundation has announced the establishment of the Jaime Peykoff Follicular Lymphoma Initiative, named for follicular lymphoma survivor and wife of Andrew Peykoff II, owner of Niagara Bottling.
Established through the gift of the Peykoff Family and Niagara Cares, the $10 million initiative is designed to convene experts in follicular lymphoma research and patient care, accelerate therapeutic development, and to drive direct investment in clinical research.
LRF assembled a steering committee comprising FL experts to provide thought leadership for the Initiative. This multidisciplinary, multi-institutional panel will ensure all key stakeholders are informed of the initiative’s goals and identify the most significant areas of unmet needs in clinical FL research. The initiative’s steering committee includes the following:
Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, Chair
Sonali M. Smith, MD, The University of Chicago Medical Center, Vice Chair
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester
John P. Leonard, MD, Weill Cornell Medicine
Brian Link, MD, University of Iowa, Holden Comprehensive Cancer Center
Laura Pasqualucci, MD, Columbia University Medical Center
John Timmerman, MD, UCLA Jonsson Comprehensive Cancer Center
LRF will develop an international scientific workshop to drive collaboration. Follicular lymphoma thought leaders would share early research findings, discuss the results of pivotal clinical trials, and engage in planning exercises designed to advance FL research.
Under the leadership of the Jaime Peykoff Follicular Lymphoma Initiative Steering Committee and the LRF SAB, LRF will fund both Clinical Investigator Career Development Awards and Senior Investigator Grants to attract senior and early-career investigators and train them in the field of FL research.
For more information about the Jaime Peykoff Follicular Lymphoma Initiative or additional LRF research programs, visit www.lymphoma.org/research.
